Theranos lays off most of its remaining workforce: WSJ
(Reuters) – Embattled blood-testing company Theranos Inc laid off most of its remaining workforce to preserve cash and avert or at least delay bankruptcy for a few more months, the…
by October Gallery
(Reuters) – Embattled blood-testing company Theranos Inc laid off most of its remaining workforce to preserve cash and avert or at least delay bankruptcy for a few more months, the…
WASHINGTON (Reuters) – Facebook (FB.O) Chief Executive Mark Zuckerberg’s No. 1 mission during his appearance before U.S. lawmakers on Tuesday and Wednesday will be to defend against calls to regulate…
Media in Myanmar is undergoing a slow transformation. Where censorship and government regulation were the norm for decades, now private publications are being established. International media,… source
NEW DELHI (Reuters) – A special court of India’s Central Bureau of Investigation (CBI) issued non-bailable warrants against two Indian jewelers who are central figures in an alleged $2 billion…
(Reuters Health) – New research reveals serious flaws in the animal studies that regulators and ethicists use to decide if an experimental drug should be tested in humans. Dr. Daniel…
LONDON (Reuters) – The company that makes British passports will challenge the decision to use a foreign firm in future, a government decision that some eurosceptics in the tabloid press…
(Reuters) – Pfizer Inc said on Tuesday it signed an agreement with Allogene Therapeutics, a company formed by a consortium in which the drugmaker will hold a 25 percent stake,…
(Reuters) – Walmart Inc’s (WMT.N) efforts to develop closer ties with health insurer Humana Inc (HUM.N), which came to light on Thursday, point to a brave new world of retail…
(Reuters) – U.S. President Donald Trump launched his second attack in a week on Amazon.com Inc on Saturday, accusing the world’s biggest online retailer of getting unfairly cheap rates from…
(Reuters) – Arkansas’ attorney general on Thursday joined the widening mass of litigation against opioid manufacturers, accusing three drugmakers of promoting addictive painkillers in ways that falsely denied or trivialized…